Accounts receivable, net of allowance for credit losses of 80,423 and 75,000 at june 30, 2025 and september 30, 2024, respectively
199,047
Total current assets
5,628,902
Restricted cash
750,000
Property and equipment, net
511,203
Operating right of use asset
334,402
Intangible assets
2,698,975
Noncurrent assets of discontinued operations
11,264
Total assets
9,934,746
Accounts payable and accrued liabilities
1,564,707
Operating lease liability, current
334,403
Current liabilities of discontinued operations
124,565
Deferred revenue
12,285
Total current liabilities
2,035,960
Deferred tax liability, net
684,115
Deferred revenue, long term
194,000
Long term accrued liabilities
31,467
Warrants classified as a liability
1,160
Total liabilities
2,946,702
Accumulated deficit
-373,888,601
Common stock, par value 0.001 per share 200,000,000 shares authorized as of june 30, 2025 and september 30, 2024 901,500 and 13,755 shares issued and outstanding as of june 30, 2025 and september 30, 2024, respectively
902
Additional paid in capital
381,150,267
Applied dna sciences, inc. stockholders' equity
7,262,568
Noncontrolling interest
-274,524
Total equity
6,988,044
Total liabilities and equity
9,934,746
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.